Home
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Teva Puts End Of 2022 Ambition On Nationwide US Opioids Settlement
‘We Believe We’re Getting Closer,’ Says CEO Kåre Schultz
May 06 2022
•
By
Dean Rudge
Teva has nationwide ambitions with a trial in California to come • Source: Shutterstock: Savvapanf Photo
More from Generics
More from Products